These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11427614)

  • 21. Cytochrome P450 activity and endothelial dysfunction in insulin resistance.
    Katakam PV; Hoenig M; Ujhelyi MR; Miller AW
    J Vasc Res; 2000; 37(5):426-34. PubMed ID: 11025406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.
    Si H; Heyken WT; Wölfle SE; Tysiac M; Schubert R; Grgic I; Vilianovich L; Giebing G; Maier T; Gross V; Bader M; de Wit C; Hoyer J; Köhler R
    Circ Res; 2006 Sep; 99(5):537-44. PubMed ID: 16873714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.
    Nagao T; Vanhoutte PM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):1-6. PubMed ID: 8380248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery.
    Zygmunt PM; Edwards G; Weston AH; Davis SC; Högestätt ED
    Br J Pharmacol; 1996 Jul; 118(5):1147-52. PubMed ID: 8818337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
    Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
    Rath G; Dessy C; Feron O
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
    Rajagopalan S; Kurz S; Münzel T; Tarpey M; Freeman BA; Griendling KK; Harrison DG
    J Clin Invest; 1996 Apr; 97(8):1916-23. PubMed ID: 8621776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease.
    Luksha L; Agewall S; Kublickiene K
    Atherosclerosis; 2009 Feb; 202(2):330-44. PubMed ID: 18656197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-dependent hyperpolarization of vascular smooth muscle cells.
    Félétou M; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Jan; 21(1):1-18. PubMed ID: 11263241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local regulation of vascular tone and growth.
    Noll G; Lüscher TF
    Exp Nephrol; 1994; 2(2):78-91. PubMed ID: 8082019
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery.
    Fukao M; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Br J Pharmacol; 1997 Feb; 120(3):439-46. PubMed ID: 9031747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EDHF -- are there gaps in the pathway?
    Edwards G; Weston AH
    J Physiol; 2001 Mar; 531(Pt 2):299. PubMed ID: 11310433
    [No Abstract]   [Full Text] [Related]  

  • 34. A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.
    Popp R; Bauersachs J; Hecker M; Fleming I; Busse R
    J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):699-709. PubMed ID: 9003555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation.
    de Wit C; Esser N; Lehr HA; Bolz SS; Pohl U
    Am J Physiol; 1999 May; 276(5):H1527-34. PubMed ID: 10330235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cytochrome P450.
    Schwartzman ML; McGiff JC
    J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):229-42. PubMed ID: 8777568
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues.
    Enayetallah AE; French RA; Thibodeau MS; Grant DF
    J Histochem Cytochem; 2004 Apr; 52(4):447-54. PubMed ID: 15033996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone.
    Campbell WB; Harder DR
    Circ Res; 1999 Mar; 84(4):484-8. PubMed ID: 10066684
    [No Abstract]   [Full Text] [Related]  

  • 39. Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice.
    Krummen S; Falck JR; Thorin E
    Br J Pharmacol; 2005 May; 145(2):264-70. PubMed ID: 15765099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity.
    Tsai SH; Hein TW; Kuo L; Yang VC
    Microvasc Res; 2011 Nov; 82(3):356-63. PubMed ID: 21983453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.